GABY Inc. announced the appointment of Paul Stacey to the role of Chief Financial Officer effective immediately. Mr. Stacey will succeed GABY's current Chief Financial Officer, Marshall Minor, who has announced his intention to explore additional opportunities elsewhere. Mr. Minor will transition day to day responsibility to Mr. Stacey, and will remain engaged with GABY in a consulting capacity until April 30, 2022 to enable him to conclude several projects, including the audit of GABY's fiscal year ending December 2021.

Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys - a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds.

As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PricewaterhouseCoopers.